Spinal Devices: Looking for a Twist Rather than a Tweak
This article was originally published in Start Up
Executive Summary
Medical device investors still see great potential in companies developing products to treat the spine. But they're particularly eager to find companies with fresh new approaches toward treatments rather than those that offer a marginal improvement to current products on the market.
You may also be interested in...
In Brief
Brief summaries of recent developments in the medical device industry.
Start-Up Previews (02/07)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: Spine Devices: Looking for a Twist Rather than a Tweaks, features profiles of CoreSpine, Interventional Spine, and Paradigm Spine. Plus these Start-Ups Across Health Care: Claros Diagnostics, Cure Therapeutics, Enigma Diagnosics, Generic Medical Devices, and Nitec Pharma.
Strength in Spine
Those venture capitalists and other investors who have been suggesting recently that the spinal device market is overheated, overcrowded, and basically over as a prime investment opportunity were few and far between at Windhover's "In Spine and Orthopedics" conference held in Las Vegas in December. The meeting, which is the largest strategic partnering conference for emerging spine and orthopedic companies, found investors and entrepreneurs feeling bullish about the prospects for the spinal device market, as reflected in the panel discussion excerpted here.